Positive results for mRNA vaccine in melanoma patients
Moderna and MSD have announced follow-up data from the Phase IIb clinical trial evaluating cancer vaccine mRNA-4157 in combination with MSDs Keytruda in patients with resected high-risk...
United Kingdom United States Aboutsurperformance Sasabout Kyle Holen Europe America Asia Nederlands Belgi
Source: marketscreener.com